201 related articles for article (PubMed ID: 14764738)
1. Respective roles of decay-accelerating factor and CD59 in circumventing glomerular injury in acute nephrotoxic serum nephritis.
Lin F; Salant DJ; Meyerson H; Emancipator S; Morgan BP; Medof ME
J Immunol; 2004 Feb; 172(4):2636-42. PubMed ID: 14764738
[TBL] [Abstract][Full Text] [Related]
2. Decay-accelerating factor confers protection against complement-mediated podocyte injury in acute nephrotoxic nephritis.
Lin F; Emancipator SN; Salant DJ; Medof ME
Lab Invest; 2002 May; 82(5):563-9. PubMed ID: 12003997
[TBL] [Abstract][Full Text] [Related]
3. Decay-accelerating factor but not CD59 limits experimental immune-complex glomerulonephritis.
Bao L; Haas M; Minto AW; Quigg RJ
Lab Invest; 2007 Apr; 87(4):357-64. PubMed ID: 17259999
[TBL] [Abstract][Full Text] [Related]
4. CD59a deficiency exacerbates accelerated nephrotoxic nephritis in mice.
Turnberg D; Botto M; Warren J; Morgan BP; Walport MJ; Cook HT
J Am Soc Nephrol; 2003 Sep; 14(9):2271-9. PubMed ID: 12937303
[TBL] [Abstract][Full Text] [Related]
5. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
Miwa T; Zhou L; Hilliard B; Molina H; Song WC
Blood; 2002 May; 99(10):3707-16. PubMed ID: 11986227
[TBL] [Abstract][Full Text] [Related]
6. Increased susceptibility of decay-accelerating factor deficient mice to anti-glomerular basement membrane glomerulonephritis.
Sogabe H; Nangaku M; Ishibashi Y; Wada T; Fujita T; Sun X; Miwa T; Madaio MP; Song WC
J Immunol; 2001 Sep; 167(5):2791-7. PubMed ID: 11509624
[TBL] [Abstract][Full Text] [Related]
7. Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice.
Turnberg D; Lewis M; Moss J; Xu Y; Botto M; Cook HT
J Immunol; 2006 Sep; 177(6):4094-102. PubMed ID: 16951374
[TBL] [Abstract][Full Text] [Related]
8. Critical protection from renal ischemia reperfusion injury by CD55 and CD59.
Yamada K; Miwa T; Liu J; Nangaku M; Song WC
J Immunol; 2004 Mar; 172(6):3869-75. PubMed ID: 15004194
[TBL] [Abstract][Full Text] [Related]
9. CD59a is the primary regulator of membrane attack complex assembly in the mouse.
Baalasubramanian S; Harris CL; Donev RM; Mizuno M; Omidvar N; Song WC; Morgan BP
J Immunol; 2004 Sep; 173(6):3684-92. PubMed ID: 15356114
[TBL] [Abstract][Full Text] [Related]
10. Heme Oxygenase 1 Up-Regulates Glomerular Decay Accelerating Factor Expression and Minimizes Complement Deposition and Injury.
Detsika MG; Duann P; Atsaves V; Papalois A; Lianos EA
Am J Pathol; 2016 Nov; 186(11):2833-2845. PubMed ID: 27662796
[TBL] [Abstract][Full Text] [Related]
11. Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells.
Bao L; Haas M; Pippin J; Wang Y; Miwa T; Chang A; Minto AW; Petkova M; Qiao G; Song WC; Alpers CE; Zhang J; Shankland SJ; Quigg RJ
J Clin Invest; 2009 May; 119(5):1264-74. PubMed ID: 19349693
[TBL] [Abstract][Full Text] [Related]
12. Complement alternative pathway activation in the autologous phase of nephrotoxic serum nephritis.
Thurman JM; Tchepeleva SN; Haas M; Panzer S; Boackle SA; Glogowska MJ; Quigg RJ; Holers VM
Am J Physiol Renal Physiol; 2012 Jun; 302(12):F1529-36. PubMed ID: 22492944
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of decay accelerating factor and CD59 leads to crisis in experimental myasthenia.
Kaminski HJ; Kusner LL; Richmonds C; Medof ME; Lin F
Exp Neurol; 2006 Dec; 202(2):287-93. PubMed ID: 16859686
[TBL] [Abstract][Full Text] [Related]
14. Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice.
Miwa T; Sato S; Gullipalli D; Nangaku M; Song WC
J Immunol; 2013 Apr; 190(7):3552-9. PubMed ID: 23427256
[TBL] [Abstract][Full Text] [Related]
15. Absence of CD59 exacerbates systemic autoimmunity in MRL/lpr mice.
Miwa T; Zhou L; Maldonado MA; Madaio MP; Eisenberg RA; Song WC
J Immunol; 2012 Dec; 189(11):5434-41. PubMed ID: 23109726
[TBL] [Abstract][Full Text] [Related]
16. Complement-independent nephrotoxic serum nephritis in Munich Wistar rats. Immunologic and ultrastructural studies.
Pilia PA; Boackle RJ; Swain RP; Ainsworth SK
Lab Invest; 1983 May; 48(5):585-97. PubMed ID: 6341711
[TBL] [Abstract][Full Text] [Related]
17. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.
Koski CL; Estep AE; Sawant-Mane S; Shin ML; Highbarger L; Hansch GM
J Neurochem; 1996 Jan; 66(1):303-12. PubMed ID: 8522968
[TBL] [Abstract][Full Text] [Related]
18. Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice.
Robson MG; Cook HT; Botto M; Taylor PR; Busso N; Salvi R; Pusey CD; Walport MJ; Davies KA
J Immunol; 2001 Jun; 166(11):6820-8. PubMed ID: 11359841
[TBL] [Abstract][Full Text] [Related]
19. Role of CD59 in experimental glomerulonephritis in rats.
Matsuo S; Nishikage H; Yoshida F; Nomura A; Piddlesden SJ; Morgan BP
Kidney Int; 1994 Jul; 46(1):191-200. PubMed ID: 7523753
[TBL] [Abstract][Full Text] [Related]
20. Glomerular complement regulation is overwhelmed in passive Heymann nephritis.
Cunningham PN; Hack BK; Ren G; Minto AW; Morgan BP; Quigg RJ
Kidney Int; 2001 Sep; 60(3):900-9. PubMed ID: 11532085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
